Nektar Therapeutics

NKTR·NasdaqCM·Healthcare
Compare
38.48+0.72 (+1.91%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close37.76
Open38.98
Day range37.5039.19
52-week range33.40109.00
Off day high−1.81%
Off 52-week high−64.70%
Volume491.95K
Avg. volume (3M)1.10M
Market cap1.31B
EPS (TTM)-18.96
Forward P/E-3.74
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.42
Shares outstanding34.14M
Short interest22.59% of float
Earnings dateNov 12, 2026
Analyst target133.08
Profit margin−287.84%

Against its peers

Compare in full ›
NKTR ARTV CRVS LKFT ACRS AKTS
Market cap 1.31B 206.32M 889.16M 2.25B 570.34M 845.42M
P/E (TTM) — — — 3.2 — —
Forward P/E -3.7 -2.1 -9.9 -28.6 -5.1 -7.1
Price/book 1.5 0.6 3.9 12.2 4.1 1.7
Dividend yield — — — — — —
1-year change −30.19% +22.67% +35.17% +9.26% +62.11% −32.14%
Today +1.91% +0.48% +7.53% +6.03% −1.60% +1.74%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Nektar Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Artiva Biotherapeutics, Inc.ARTV · Biotechnology 206.32M 4.2200 +0.48%
Corvus Pharmaceuticals, Inc.CRVS · Biotechnology 889.16M 10.57 +7.53%
Lakefront Biotherapeutics NVLKFT · Biotechnology 2.25B 34.09 +6.03%
Aclaris Therapeutics, Inc.ACRS · Biotechnology 570.34M 3.6800 −1.60%
Aktis Oncology, Inc.AKTS · Biotechnology 845.42M 15.20 +1.74%
Biohaven Ltd.BHVN · Biotechnology 2.30B 15.24 −2.37%
Odyssey Therapeutics, Inc.ODTX · Biotechnology 937.14M 19.50 −9.60%
Immunocore Holdings plcIMCR · Biotechnology 1.51B 29.23 −2.66%

Also based in San Francisco, California, then elsewhere in California.

Company Mkt cap Price Today
Visa Inc.V · San Francisco, CA 815.95B 436.57 +3.84%
Wells Fargo & CompanyWFC · San Francisco, CAOdds 262.45B 87.43 +2.22%
Salesforce, Inc.CRM · San Francisco, CAOdds 186.91B 227.11 +2.21%
Uber Technologies, Inc.UBER · San Francisco, CAOdds 142.71B 69.87 +4.91%
Airbnb, Inc.ABNB · San Francisco, CAOdds 105.61B 176.37 +5.64%
DoorDash, Inc.DASH · San Francisco, CAOdds 86.58B 198.59 +8.33%
Okta, Inc.OKTA · San Francisco, CAOdds 33.40B 191.05 +0.72%
Prologis, Inc.PLD · San Francisco, CA 127.69B 131.36 +1.77%

The stocks whose daily moves over the past year went most closely with Nektar Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Odyssey Therapeutics, Inc.ODTX · Correlation 0.35 937.14M 19.50 −9.60%

What visitors to Nektar Therapeutics's page also look at.

Company Mkt cap Price Today
Alkermes plcALKS 7.71B 45.89 +0.44%
Neurocrine Biosciences, Inc.NBIX 16.81B 166.05 +0.73%
Sangamo Therapeutics, Inc.SGMOQ 49.71M 0.1200 0.00%
Incyte CorporationINCY 25.04B 122.85 +4.47%
Exelixis, Inc.EXEL 17.75B 72.75 +0.61%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NKTR news ›

From the 4Search news index, newest first.

In the news

5mentions in 30 days
3with it in the headline
Positivesentiment

Mentioned with

Barclays3Marketbeat Ratings3Canaccord Genuity Group2Chardan Capital2Citigroup2Eli Lilly2Intellia Therapeutics2Johnson & Johnson2

People in the coverage

Michael Walen5Mitch Edgeman5Sarita Garza5Danessa Lincoln4Kim Johansen4Marketbeat4

Themes

Healthcare5EPS3Comparison2Consensus2Equities2Ratings2Review2Stock Analysis2

Most coverage from

  1. gurufocus.com1
  2. marketbeat.com1
  3. seekingalpha.com1
  4. themarketsdaily.com1
  5. tradingview.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance